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A healthy 28 year-old man with isolated oral candidiasis at17 and 26 years, on no medications, and having a recent
URI 1 week before, presented with acute-onset progressive,
painful oral mucositis and odynophagia (Fig. 1). His tempera-
ture was 101.6°F. The white blood cell count was 19.5, with
4.4% lymphocytes, 226CD4. Oral nystatin and IV caspofungin
were started. Subsequently, the patient developed injected
sclera with bilateral subconjunctival hemorrhages (Fig. 2)
and marginated, erythematous, targetoid genital papules with
vesicular centers (Fig. 3). His oral, ocular and genital lesions
corresponded to the classic distribution of Behçet’s syndrome,
initially placing this at the top of the differential diagnosis,
followed by erythema multiforme (EM) and herpes simplex.
However, generalized oral mucositis, conjunctivitis and, most
importantly, targetoid lesions are not common in Behcet’s
syndrome. Behcet’s syndrome frequently presents with
aphthous ulcers sparing the outer lips, genital ulcers and uveitis.
Figure 1. Oral ulcerations.
Figure 2. Subconjunctival hemorrhages and ocular ulcerations.
Figure 3. Scrotal and penile shaft ulcerations.
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Subsequent biopsy of the targetoid lesions demonstrated EM,
with vacuolizing keratinocytes and tagging lymphocytes. Skin
lesions and pain resolved after 1 week of high-dose methylpred-
nisolone without complications. Repeat complete blood count
(CBC) showed resolution of the lymphocytopenia. EM is a self-
limited hypersensitivity reaction to external triggers,most notably
HSV, Mycoplasma pneumoniae and medications1,2. In this
patient, HIV, HSV, M.pneumonia and Legionella studies were
negative. Traditionally, EM has been placed within the hypersen-
sitivity reaction spectrum, which includes Stevens-Johnson
syndrome and toxic epidermal necrolysis3. However, there is
suggestive evidence that EM may be a distinct entity. Treatment
targets underlying infection and removing offending agents.
Currently, systemic steroids are frequently used, but remain
controversial.
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